Category1 Category2 Category3

Davis Polk is advising PharMerica Corporation on its approximately $1.4 billion acquisition by a newly formed company controlled by KKR, with Walgreens Boots Alliance, Inc. as a minority investor. 

ID:5P5C-PXT1-JB4F-Y1G0_0